APVO Aptevo Therapeutics Inc. - Common Stock
$2,81
Preço · Ago 18, 2026
Fundamentais a partir de Ago 14, 2026
Intervalo 52 Semanas
$1–$19
10% of range
Classificação do Analista
BUY
7 analysts
Preço-Alvo
$26
+807% upside
P/E (TTM)
-0.0
ROE
-217.2%
Margem de Lucro Líquido
—
APVO Instantâneo da Ação Preço, capitalização de mercado, P/E, EPS, ROE, dívida/patrimônio, intervalo de 52 semanas
Preço
$2.81
Capitalização de Mercado
$3M
P/E (TTM)
-0.0
EPS (TTM)
$-87.27
Receita (TTM)
—
Rendimento div.
—
ROE
-217.2%
Dívida/Capital
—
Intervalo 52 Semanas
$1 – $19
APVO Gráfico de Preço da Ação OHLCV diário com indicadores técnicos — panorâmica, zoom e personalize sua visualização
Configure
Desempenho de 10 Anos Tendências de receita, lucro líquido, margens e EPS
Receita e Lucro Líquido
—
2016-12-31
→
2022-12-31
EPS
$-87.27
2021-12-31
→
2025-12-31
Fluxo de caixa livre
—
2016-12-31
→
2022-12-31
Margens
—
Avaliação Rácios P/E, P/S, P/B, EV/EBITDA — a ação está cara ou barata?
Métrica
Tendência de 5 anos
APVO
Mediana de Pares
P/E (TTM)
-0.0
—
P/S (TTM)
0.2
2.4
P/B
0.2
1.0
Lucratividade Margens bruta, operacional e líquida; ROE, ROA, ROIC
Métrica
Tendência de 5 anos
APVO
Mediana de Pares
ROA
-121.4%
-105.1%
ROE
-217.2%
-142.1%
ROIC
-151.4%
—
Saúde financeira Dívida, liquidez, solvência — força do balanço patrimonial
Métrica
Tendência de 5 anos
APVO
Mediana de Pares
Current Ratio (Índice de liquidez corrente)
3.8
1.6
Quick Ratio (Índice de Liquidez Seca)
3.6
—
Crescimento Crescimento da receita, EPS e lucro líquido: YoY, CAGR 3 anos, CAGR 5 anos
Métrica
Tendência de 5 anos
APVO
Mediana de Pares
Eficiência de Capital Giro de ativos, giro de estoques, giro de contas a receber
Métrica
Tendência de 5 anos
APVO
Mediana de Pares
APVO Consenso dos analistas Opiniões de analistas otimistas e pessimistas, preço-alvo de 12 meses, potencial de alta
COMPRA
7 analistas
- Compra forte 2 28,6%
- Compra 4 57,1%
- Manter 1 14,3%
- Venda 0 0,0%
- Venda forte 0 0,0%
Preço-alvo de 12 meses
2 analistas · 2026-08-19
Mediana
$25.50
← Abaixo de todos os alvos
$2.81
Mín
$21.00
Máx
$30.00
Alvo mediano
$25.50
+807,5%
Alvo médio
$25.50
+807,5%
Histórico de Lucros EPS real vs. estimativa, surpresa %, taxa de acerto, próxima data de resultados
Surpresa Média
-4242.2%
| Período | EPS Actual | EPS est. | Surpresa |
|---|---|---|---|
| 31 de Março de 2026 | $-6.41 | $-5.71 | -0.70% |
| 31 de Dezembro de 2025 | $-0.01 | $-8.25 | 8.2% |
| 30 de Setembro de 2025 | $-33.48 | $-38.37 | 4.9% |
| 30 de Junho de 2025 | $-151.20 | $-1527.55 | 1376.4% |
| 31 de Março de 2025 | $-1580.40 | $-1545.91 | -34.5% |
| 31 de Dezembro de 2024 | $-29653.20 | $-2845.80 | -26807.4% |
Comparação de pares (subindústria GICS) Métricas chave vs pares do setor
| Ticker | Capitalização de Mercado | P/E | Receita YoY | Margem Líquida | ROE | Margem Bruta |
|---|---|---|---|---|---|---|
| APVO | $9M | -0.1 | — | — | -217.2% | — |
| LABT | — | — | — | — | — | — |
| BCAB | — | -0.6 | — | — | — | — |
| TCRT | — | -1.5 | -50.0% | — | — | — |
| MBIO | — | -2.5 | — | — | -30.9% | — |
| MBRX | — | — | — | — | — | — |
| HCWB | — | -0.1 | -97.9% | -14677.1% | -586.8% | 20.0% |
| REVB | — | — | — | — | — | — |
| SILO | $5M | -0.7 | 0.00% | -5863.5% | -75.3% | 38.6% |
Fundamentos Completos Todas as métricas por ano — demonstração de resultados, balanço patrimonial, fluxo de caixa
Demonstração de Resultados 14
| Métrica | Tendência | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | · | · | · | $3M | $12M | $4M | $32M | $23M | $15M | $10M | $34M | |
| Cost of Revenue | · | · | · | · | · | · | $20M | $11M | $5M | $12M | $17M | |
| R&D Expense | $15M | $14M | $17M | $18M | $19M | $18M | $25M | $35M | $29M | $29M | $35M | |
| SG&A Expense | $12M | $10M | $12M | $14M | $15M | $14M | $16M | $28M | $35M | $36M | $43M | |
| Operating Income | $-26M | $-25M | $-29M | $-29M | $-21M | $-27M | $-41M | $-52M | $-54M | $-139M | $-61M | |
| Other Non-op | $345.0K | $472.0K | $578.0K | $-4M | $-8M | $-1M | $-2M | $-2M | $-2M | $-810.0K | $-237.0K | |
| Pretax Income | $-26M | $-24M | $-19M | $7M | $-29M | $-31M | $-43M | $-54M | $-56M | $-140M | $-61M | |
| Income Tax | $0 | · | · | · | · | · | · | · | $-23M | $-20M | $-2M | |
| Net Income | $-26M | $-24M | $-17M | $8M | $-28M | $-18M | $-40M | $-54M | $7M | $-112M | $-59M | |
| EPS (Basic) | $-87.27 | $-31460.23 | $-2316.83 | $1.57 | $-6.07 | · | · | · | · | · | · | |
| EPS (Diluted) | $-87.27 | $-31460.23 | $-2316.83 | $1.57 | $-6.07 | · | · | · | · | · | · | |
| Shares (Basic) | 315,535 | 767 | 7,515 | 5,100,310 | 4,687,952 | · | · | · | · | · | · | |
| Shares (Diluted) | 315,535 | 767 | 7,515 | 5,102,914 | 4,687,952 | · | · | · | · | · | · | |
| EBITDA | $-26M | $-24M | $-28M | $-28M | $-20M | · | $-40M | $-49M | · | $-124M | · |
Balanço Patrimonial 28
| Métrica | Tendência | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $22M | $9M | $17M | $23M | $45M | $40M | $12M | $31M | $7M | $10M | $5M | |
| Short-term Investments | · | · | · | · | · | · | · | · | $74M | $45M | · | |
| Receivables | · | · | · | · | · | · | $7M | $5M | $2M | $307.0K | $6M | |
| Inventory | · | · | · | · | · | · | $6M | $2M | $1M | $461.0K | $20M | |
| Prepaid Expense | $1M | $2M | $1M | $2M | $2M | $2M | $1M | $7M | $4M | $6M | $2M | |
| Other Current Assets | $853.0K | $1M | $689.0K | $744.0K | $780.0K | $133.0K | $160.0K | $4M | $7M | $2M | · | |
| Current Assets | $23M | $11M | $19M | $27M | $53M | $47M | $30M | $49M | $95M | $71M | $35M | |
| PP&E (Net) | $303.0K | $543.0K | $895.0K | $1M | $2M | $3M | $4M | $5M | $6M | $6M | $4M | |
| PP&E (Gross) | $14M | $14M | $14M | $14M | $15M | $14M | $14M | $14M | $13M | $13M | $10M | |
| Accum. Depreciation | $14M | $14M | $14M | $13M | $12M | $11M | $10M | $9M | $8M | $7M | $6M | |
| Goodwill | · | · | · | · | · | · | · | · | · | · | $29M | |
| Intangibles | · | · | · | · | · | · | $4M | $5M | $6M | $7M | · | |
| Other Non-current Assets | · | · | · | · | $68.0K | $746.0K | $757.0K | $905.0K | · | · | · | |
| Total Assets | $27M | $16M | $25M | $34M | $57M | $54M | $53M | $67M | $117M | $92M | $128M | |
| Accounts Payable | $877.0K | $1M | · | · | · | · | $6M | $12M | · | · | $10M | |
| Current Liabilities | $6M | $6M | $7M | $9M | $35M | $15M | $38M | $18M | $19M | $20M | $20M | |
| Capital Leases | $4M | $5M | $5M | $6M | $1M | $2M | $3M | · | · | · | · | |
| Deferred Tax | · | · | · | · | · | · | · | · | · | · | $16M | |
| Other Non-current Liabilities | · | $0 | · | · | · | · | · | $200.0K | $734.0K | $469.0K | $71.0K | |
| Total Liabilities | $10M | $11M | $13M | $16M | $55M | $37M | $42M | $37M | $35M | $41M | $39M | |
| Long-term Debt | · | · | $0 | $4M | $16M | $28M | · | · | $19M | · | · | |
| Total Debt | · | · | · | $3M | $12M | · | $20M | $19M | · | $18M | · | |
| Common Stock | $114.0K | $84.0K | $61.0K | $48.0K | $47.0K | $46.0K | $45.0K | $23.0K | $22.0K | $20.0K | · | |
| Retained Earnings | $-275M | $-248M | $-223M | $-206M | $-214M | $-186M | $-168M | $-127M | $-74M | $-81M | $-232M | |
| AOCI | · | · | · | · | · | · | · | · | $-105.0K | $-33.0K | · | |
| Stockholders' Equity | $17M | $5M | $12M | $18M | $1M | $17M | $12M | $30M | $82M | $51M | $89M | |
| Liabilities + Equity | $27M | $16M | $25M | $34M | $57M | $54M | $53M | $67M | $117M | $92M | $128M | |
| Shares Outstanding | 997,830 | 4,051 | 11,958 | 6,466,294 | 4,898,143 | 4,410,909 | 3,234,231 | 22,808,416 | 21,605,716 | 20,271,737 | 0 |
Fluxo de Caixa 16
| Métrica | Tendência | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $240.0K | $352.0K | $567.0K | $901.0K | $1M | $1M | $2M | $2M | $3M | $3M | $3M | |
| Stock-based Comp | $96.0K | $1M | $2M | $2M | $2M | $1M | $2M | $2M | $5M | $4M | $1M | |
| Deferred Tax | · | · | · | · | · | · | · | · | $-11M | $-15M | $-1M | |
| Amort. of Intangibles | · | · | · | · | · | · | $800.0K | $800.0K | $800.0K | $800.0K | $3M | |
| Other Non-cash | $39.0K | $-1M | $3M | $-32M | $4M | · | $-6M | $-2M | · | $84M | · | |
| Operating Cash Flow | $-26M | $-24M | $-12M | $-21M | $-22M | $-29M | $-42M | $-51M | $-42M | $-37M | $-49M | |
| CapEx | · | · | · | $29.0K | $713.0K | $88.0K | $153.0K | $976.0K | $1M | $3M | $2M | |
| Investing Cash Flow | $0 | $0 | $0 | $-29.0K | $-713.0K | $28M | $4M | $73M | $29M | · | · | |
| Debt Issued | · | · | · | · | · | · | · | · | · | $20M | · | |
| Net Debt Issued | · | $0 | $-3M | $-12M | $-11M | · | · | · | · | $20M | · | |
| Stock Issued | $38M | $10M | $6M | $7M | $10M | · | · | $623.0K | $442.0K | · | · | |
| Net Stock Activity | $38M | $10M | · | $7M | $10M | · | · | $623.0K | · | · | · | |
| Financing Cash Flow | $38M | $16M | $6M | $-3M | $26M | $24M | $20M | $-787.0K | $20M | · | · | |
| Net Change in Cash | $13M | $-8M | $-6M | $-24M | $4M | $23M | $-18M | $21M | $7M | $5M | $1M | |
| Taxes Paid | $0 | $0 | · | · | · | · | · | · | · | · | · | |
| Free Cash Flow | · | · | · | $-21M | $-22M | · | $-43M | $-52M | · | $-39M | · |
Lucratividade 7
| Métrica | Tendência | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Margin | · | · | · | -919.8% | -174.1% | · | -131.4% | -224.0% | · | -348.4% | · | |
| Net Margin | · | · | · | 257.8% | -231.5% | · | -124.8% | -232.8% | · | -308.5% | · | |
| Pretax Margin | · | · | · | 225.2% | -239.2% | · | -137.8% | -232.8% | · | -350.6% | · | |
| EBITDA Margin | · | · | · | -890.8% | -164.8% | · | -124.5% | -213.6% | · | -339.2% | · | |
| ROA | -121.4% | -119.4% | -59.0% | 17.7% | -51.7% | · | -66.9% | -58.2% | · | -99.8% | · | |
| ROE | -217.2% | -526.0% | -129.3% | 47.6% | -668.9% | · | -256.1% | -144.3% | · | -152.2% | · | |
| ROIC | -151.4% | · | · | · | · | · | · | · | · | -162.0% | · |
Liquidez e Solvência 4
| Métrica | Tendência | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 3.8 | 1.7 | 2.6 | 3.2 | 1.5 | · | 0.8 | 2.8 | · | 3.7 | · | |
| Quick Ratio | 3.6 | 1.4 | 2.3 | 2.6 | 1.3 | · | 0.5 | 2.0 | · | 3.0 | · | |
| Debt / Equity | · | · | · | 0.2 | 9.6 | · | 1.7 | 0.6 | · | 0.4 | · | |
| LT Debt / Equity | · | · | · | 0.1 | · | · | · | 0.6 | · | 0.4 | · |
Eficiência 3
| Métrica | Tendência | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | · | · | · | 0.1 | 0.2 | · | 0.5 | 0.2 | · | 0.3 | · | |
| Inventory Turnover | · | · | · | · | · | · | 5.0 | · | · | 1.8 | · | |
| Receivables Turnover | · | · | · | · | · | · | 5.3 | 6.3 | · | 6.8 | · |
Taxas de Crescimento 1
| Métrica | Tendência | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY | · | · | · | -74.7% | 185.3% | · | · | · | · | · | · |
Avaliação (TTM) 14
| Métrica | Tendência | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $12M | $12M | $12M | $3M | $12M | $4M | $32M | $23M | $15M | $10M | · | |
| Net Income TTM | $-26M | $-24M | $-17M | $8M | $-28M | $-18M | $-40M | $-54M | $7M | $-112M | · | |
| Market Cap | $9M | $126M | $114.73B | $488.46B | $1.26T | · | $13.52T | $13.20T | · | $22.55T | · | |
| Enterprise Value | · | · | · | $488.44B | $1.26T | · | $13.52T | $13.20T | · | $22.55T | · | |
| P/E | -0.1 | -0.0 | -2.5 | 48114.1 | -42215.4 | · | · | · | · | · | · | |
| P/S | 0.8 | 10.7 | 9772.0 | 156858.9 | 102109.9 | · | 416952.2 | 572427.1 | · | 2258110.4 | · | |
| P/B | 0.5 | 26.4 | 9388.2 | 27175.8 | 1032183.8 | · | 1141636.4 | 434262.2 | · | 445897.1 | · | |
| P / Tangible Book | 0.5 | 26.4 | 9388.2 | 27175.8 | 1032183.8 | 317201.6 | · | · | · | · | · | |
| P / Cash Flow | -0.4 | -5.3 | -9781.2 | -23235.6 | -57896.4 | · | -318978.3 | -256780.7 | · | -611666.0 | · | |
| P / FCF | · | · | · | -23203.6 | -56052.9 | · | -317831.0 | -251997.7 | · | -572642.7 | · | |
| EV / EBITDA | · | · | · | -17607.8 | -61962.0 | · | -334958.7 | -267968.8 | · | -182445.8 | · | |
| EV / FCF | · | · | · | -23202.7 | -56051.4 | · | -317831.2 | -251997.5 | · | -572641.7 | · | |
| EV / Revenue | · | · | · | 156852.8 | 102107.2 | · | 416952.4 | 572426.6 | · | 2258106.7 | · | |
| Earnings Yield | -925.5% | -36496.8% | -39.3% | 0.00% | 0.00% | · | · | · | · | · | · |
Demonstração de Resultados 11
| Métrica | Tendência | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | · | · | · | · | · | · | · | · | · | · | · | · | · | · | $0 | $0 | |
| R&D Expense | $4M | $4M | $4M | $4M | $3M | $4M | $4M | $3M | $4M | $4M | $4M | $4M | $5M | $4M | $5M | $4M | |
| SG&A Expense | $3M | $3M | $2M | $4M | $3M | $3M | $3M | $2M | $2M | $3M | $3M | $3M | $3M | $4M | $3M | $3M | |
| Operating Income | $-6M | $-7M | $-6M | $-8M | $-6M | $-6M | $-6M | $-5M | $-6M | $-7M | $-6M | $-7M | $-8M | $-8M | $-8M | $-8M | |
| Other Non-op | $87.0K | $140.0K | $190.0K | $61.0K | $22.0K | $72.0K | $70.0K | $112.0K | $141.0K | $149.0K | $188.0K | $227.0K | $230.0K | $-67.0K | $21.0K | $-25.0K | |
| Net Income | $-6M | $-7M | $-6M | $-8M | $-6M | $-6M | $-6M | $-5M | $-6M | $-7M | $-6M | $-6M | $-8M | $3M | $-5M | $-8M | |
| EPS (Basic) | $-5.31 | $-6.41 | $-72.25 | $-2.23 | $-151.29 | $-1581.81 | $-29497.20 | $-357.86 | $-1236.96 | $-368.21 | $-2258.10 | $-22.16 | $-53.95 | $17.38 | $-0.96 | $-1.50 | |
| EPS (Diluted) | $-5.31 | $-6.41 | $-72.25 | $-2.23 | $-151.29 | $-1581.81 | $-29497.20 | $-357.86 | $-1236.96 | $-368.21 | $-2258.10 | $-22.16 | $-53.95 | $17.38 | $-0.96 | $-1.50 | |
| Shares (Basic) | 1,196,364 | 1,060,678 | -5,930,118 | 4,049,046 | 41,008 | 4,051 | -36,803 | 14,254 | 4,756 | 18,560 | -585,289 | 285,886 | 147,321 | 159,597 | -9,951,059 | 5,090,592 | |
| Shares (Diluted) | 1,196,364 | 1,060,678 | -5,930,118 | 4,049,046 | 41,008 | 4,051 | -36,803 | 14,254 | 4,756 | 18,560 | -585,289 | 285,886 | 147,321 | 159,597 | -9,948,455 | 5,090,592 | |
| EBITDA | $-6M | · | · | $-8M | $-6M | $-6M | · | $-5M | $-6M | $-7M | · | $-7M | $-8M | $-8M | · | $-8M |
Balanço Patrimonial 20
| Métrica | Tendência | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $10M | $15M | $22M | $21M | $9M | $2M | $9M | $8M | $8M | $10M | $17M | $19M | $21M | $25M | $23M | $22M | |
| Prepaid Expense | $1M | $1M | $1M | $2M | $2M | $1M | $2M | $2M | $798.0K | $1M | $1M | $1M | $910.0K | $2M | $2M | $1M | |
| Other Current Assets | $462.0K | $851.0K | $853.0K | $77.0K | $82.0K | $120.0K | $1M | $624.0K | $715.0K | $691.0K | $689.0K | $649.0K | $764.0K | $2M | $744.0K | $658.0K | |
| Current Assets | $11M | $16M | $23M | $23M | $11M | $4M | $11M | $10M | $10M | $12M | $19M | $21M | $23M | $28M | $27M | $25M | |
| PP&E (Net) | $236.0K | $268.0K | $303.0K | $384.0K | $432.0K | $482.0K | $543.0K | $614.0K | $697.0K | $789.0K | $895.0K | $1M | $1M | $1M | $1M | $2M | |
| PP&E (Gross) | · | · | $14M | · | · | · | $14M | · | · | · | $14M | · | · | · | $14M | · | |
| Accum. Depreciation | · | · | $14M | · | · | · | $14M | · | · | · | $14M | · | · | · | $13M | · | |
| Total Assets | $15M | $20M | $27M | $27M | $16M | $8M | $16M | $15M | $15M | $18M | $25M | $27M | $29M | $35M | $34M | $32M | |
| Accounts Payable | $1M | $890.0K | $877.0K | · | · | · | $1M | · | · | · | · | · | · | · | · | · | |
| Current Liabilities | $5M | $5M | $6M | $6M | $5M | $5M | $6M | $6M | $5M | $6M | $7M | $7M | $7M | $6M | $9M | $8M | |
| Capital Leases | $3M | $4M | $4M | $4M | $4M | $4M | $5M | $5M | $5M | $5M | $5M | $6M | $6M | $6M | $6M | $6M | |
| Other Non-current Liabilities | · | · | · | · | · | · | · | $14.0K | $14.0K | $14.0K | · | · | · | · | · | · | |
| Total Liabilities | $8M | $8M | $10M | $10M | $9M | $10M | $11M | $11M | $10M | $12M | $13M | $12M | $13M | $12M | $16M | $16M | |
| Long-term Debt | · | · | · | · | · | · | · | · | · | · | · | $0 | $0 | $0 | $3M | $4M | |
| Total Debt | · | · | · | · | · | · | · | · | · | · | · | · | · | · | · | $4M | |
| Common Stock | $114.0K | $114.0K | $114.0K | $110.0K | $99.0K | $84.0K | $84.0K | $82.0K | $69.0K | $66.0K | $61.0K | $56.0K | $49.0K | $49.0K | $48.0K | $47.0K | |
| Retained Earnings | $-288M | $-282M | $-275M | $-269M | $-260M | $-254M | $-248M | $-241M | $-236M | $-230M | $-223M | $-218M | $-211M | $-203M | $-206M | $-201M | |
| Stockholders' Equity | $6M | $12M | $17M | $17M | $7M | $-1M | $5M | $4M | $4M | $6M | $12M | $15M | $16M | $23M | $18M | $16M | |
| Liabilities + Equity | $15M | $20M | $27M | $27M | $16M | $8M | $16M | $15M | $15M | $18M | $25M | $27M | $29M | $35M | $34M | $32M | |
| Shares Outstanding | 1,418,952 | 1,203,753 | 997,830 | 13,808,966 | 3,224,156 | 1,458,504 | 4,051 | 17,050,536 | 4,080,665 | 673,430 | 11,958 | 14,465,703 | 7,543,440 | 7,239,471 | 6,466,294 | 5,090,644 |
Fluxo de Caixa 11
| Métrica | Tendência | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $32.0K | $35.0K | $81.0K | $49.0K | $49.0K | $61.0K | $71.0K | $84.0K | $91.0K | $106.0K | $116.0K | $123.0K | $150.0K | $178.0K | $161.0K | $222.0K | |
| Stock-based Comp | $58.0K | $57.0K | $2.0K | $77.0K | $-163.0K | $180.0K | $-72.0K | $149.0K | $273.0K | $719.0K | $358.0K | $455.0K | $465.0K | $915.0K | $357.0K | $359.0K | |
| Other Non-cash | · | · | · | · | · | $-408.0K | · | · | · | $-642.0K | · | · | · | $700.0K | · | · | |
| Operating Cash Flow | $-5M | $-8M | $-5M | $-7M | $-7M | $-7M | $-6M | $-5M | $-6M | $-7M | $-5M | $-6M | $-5M | $5M | $-6M | $-7M | |
| CapEx | · | · | · | · | · | · | · | · | · | · | · | · | · | · | $0 | $4.0K | |
| Investing Cash Flow | $0 | $0 | · | · | $0 | $0 | · | · | · | · | · | · | · | · | $0 | $-4.0K | |
| Net Debt Issued | · | · | · | · | · | · | · | · | · | · | · | · | · | $-3M | · | · | |
| Stock Issued | $726.0K | $872.0K | $32M | $-9M | $14M | $0 | · | $6M | · | · | $3M | $1M | $481.0K | $2M | · | $0 | |
| Net Stock Activity | · | · | · | · | · | · | · | $6M | · | · | · | · | · | $2M | · | · | |
| Financing Cash Flow | $726.0K | $871.0K | $6M | $18M | $14M | $0 | $7M | $5M | $4M | $-3.0K | $3M | $4M | $481.0K | $-2M | $6M | $-500.0K | |
| Net Change in Cash | $-5M | $-7M | $558.0K | $12M | $7M | $-7M | $961.0K | $-313.0K | $-2M | $-7M | $-2M | $-2M | $-4M | $3M | $59.0K | $-7M |
Lucratividade 2
| Métrica | Tendência | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ROA | -42.2% | · | · | -35.8% | -40.6% | -49.4% | · | -24.1% | -26.8% | -26.0% | · | -21.5% | -23.5% | 6.9% | · | -16.0% | |
| ROE | -101.2% | · | · | -69.2% | -112.9% | -276.8% | · | -53.3% | -56.8% | -46.6% | · | -41.6% | -40.5% | 31.9% | · | -66.3% |
Liquidez e Solvência 4
| Métrica | Tendência | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 2.1 | · | · | 4.0 | 2.3 | 0.7 | · | 1.7 | 1.8 | 1.9 | · | 3.1 | 3.3 | 4.9 | · | 3.2 | |
| Quick Ratio | 1.9 | · | · | 3.8 | 1.9 | 0.4 | · | 1.3 | 1.5 | 1.6 | · | 2.8 | 3.0 | 4.4 | · | 2.8 | |
| Debt / Equity | · | · | · | · | · | · | · | · | · | · | · | · | · | · | · | 0.2 | |
| LT Debt / Equity | · | · | · | · | · | · | · | · | · | · | · | · | · | · | · | 0.1 |
Avaliação (TTM) 12
| Métrica | Tendência | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $12M | $12M | · | $12M | $12M | $12M | · | $12M | $12M | $12M | · | $12M | $12M | $12M | · | $12M | |
| Net Income TTM | $-27M | $-27M | · | $-25M | $-24M | $-24M | · | $-24M | $-27M | $-18M | · | $-19M | $15M | $15M | · | $6M | |
| Market Cap | $6M | · | · | $20M | $10M | $34M | · | $2.27B | $924M | $2.34B | · | $155.43B | $358.60B | $479.68B | · | $503.88B | |
| Enterprise Value | · | · | · | · | · | · | · | · | · | · | · | · | · | · | · | $503.87B | |
| P/E | -0.0 | -0.0 | · | -0.0 | -0.0 | -0.0 | · | -0.1 | -0.1 | -8.1 | · | -178.4 | -1463.1 | 3328.0 | · | 89984.0 | |
| P/S | 0.5 | · | · | 1.7 | 0.8 | 2.9 | · | 193.4 | 78.7 | 199.1 | · | 13238.3 | 30542.3 | 40855.5 | · | 42916.6 | |
| P/B | 1.0 | · | · | 1.2 | 1.5 | -23.0 | · | 513.8 | 207.0 | 383.0 | · | 10560.6 | 22063.4 | 20626.3 | · | 31968.3 | |
| P / Tangible Book | 1.0 | 0.4 | · | 1.2 | 1.5 | · | · | 513.8 | 207.0 | 383.0 | · | 10560.6 | 22063.4 | 20626.3 | · | 31968.3 | |
| P / Cash Flow | · | · | · | · | · | -5.1 | · | · | · | -351.4 | · | · | · | 105055.7 | · | · | |
| EV / EBITDA | · | · | · | · | · | · | · | · | · | · | · | · | · | · | · | -64731.0 | |
| EV / Revenue | · | · | · | · | · | · | · | · | · | · | · | · | · | · | · | 42915.1 | |
| Earnings Yield | -3721.6% | -37443.8% | · | -25715.9% | -52708.5% | -8480.3% | · | -1490.4% | -742.5% | -12.3% | · | -0.56% | -0.07% | 0.03% | · | 0.00% |
Demonstrações Financeiras Demonstração de resultados, balanço patrimonial, fluxo de caixa — anual, últimos 5 anos
Demonstração de Resultados
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| Receita | — | — | — | $3M | $12M |
| Margem Operacional % | — | — | — | -919.8% | -174.1% |
| Lucro líquido | $-26M | $-24M | $-17M | $8M | $-28M |
| EPS Diluído | $-87.27 | $-31460.23 | $-2316.83 | $1.57 | $-6.07 |
Balanço Patrimonial
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| Dívida / Patrimônio Líquido | — | — | — | 0.2 | 9.6 |
| Índice de liquidez corrente | 3.8 | 1.7 | 2.6 | 3.2 | 1.5 |
| Índice de Liquidez Seca | 3.6 | 1.4 | 2.3 | 2.6 | 1.3 |
Fluxo de Caixa
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| Fluxo de caixa livre | — | — | — | $-21M | $-22M |
Minhas Métricas Sua lista pessoal — linhas selecionadas de Fundamentos Completos
📊
Escolha as métricas que importam para você — clique no ➕ ao lado de qualquer linha em Fundamentos Completos acima.
Sua seleção é salva e acompanha você em todos os tickers.
Investidores institucionais (13F) 11 declarantes · $152K total · Em 30 de Junho de 2026
Instituições que relatam a posse desta ação em seu Formulário 13F trimestral da SEC. Apenas posições compradas; um único declarante pode aparecer duas vezes para opções separadas. Grandes posições de compra/venda compensatórias geralmente refletem market-making ou inventário protegido, não convicção direcional.
Atividade institucional — Q2 2026 vs trimestre anterior
| Novas posições | Posições encerradas | Aumentou | Diminuído | Variação líquida de ações |
|---|---|---|---|---|
| 3 (+1 vs trimestre anterior) | 0 (-4 vs trimestre anterior) | 1 (-1 vs trimestre anterior) | 2 (+1 vs trimestre anterior) | +13K |
Comparado a Q1 2026. Os registros do Formulário 13F da SEC devem ser feitos em até 45 dias após o final do trimestre, mais um pequeno período de tolerância para registrantes atrasados — trimestres ainda dentro desse período são ignorados em favor do par mais recente totalmente reportado.
| Instituição | Valor | Ações | % de 13F rastreado | Tipo |
|---|---|---|---|---|
| VANGUARD CAPITAL MANAGEMENT LLC | $56.446 | 12.713 | 37,24% | Ações |
| VANGUARD GROUP INC | $39.059 | 4.142 | 25,77% | Ações |
| GEODE CAPITAL MANAGEMENT, LLC | $35.222 | 7.933 | 23,24% | Ações |
| VANGUARD FIDUCIARY TRUST CO | $18.390 | 4.142 | 12,13% | Ações |
| OSAIC HOLDINGS, INC. | $1.596 | 360 | 1,05% | Ações |
| SBI Securities Co., Ltd. | $484 | 109 | 0,32% | Ações |
| BARCLAYS PLC | $138 | 31 | 0,09% | Ações |
| UBS Group AG | $98 | 22 | 0,06% | Ações |
| GSA CAPITAL PARTNERS LLP | $96 | 21.539 | 0,06% | Ações |
| CWM, LLC | $21 | 5 | 0,01% | Ações |
| DANSKE BANK A/S | $4 | 1 | 0,00% | Ações |
Executivos da empresa 17 insiders · 5 diretores · 1 conselheiros
| Investidor com informação privilegiada | Função | Última atividade | Ações detidas | Compras 12m | Vendas 12m | Líquido 12m |
|---|---|---|---|---|---|---|
| Jane A Gross | SVP & Chief Scientific Officer | 29 de Janeiro de 2021 A | 109.583 | 0 | 0 | $0 |
| Randy Joe Maddux | SVP of Operations, CMO | 27 de Julho de 2020 A | 75.000 | 0 | 0 | $0 |
| Michael Adelman | SVP, Commercial Operations | 18 de Fevereiro de 2020 A | 70.426 | 0 | 0 | $0 |
| Shawnte Mitchell | SVP, GC and Corporate Affairs | 18 de Fevereiro de 2020 A | 80.527 | 0 | 0 | $0 |
| Scott C Stromatt | Chief Medical Officer and SVP | 1 de Março de 2019 M | 216.183 | 0 | 0 | $0 |
| Fuad El-Hibri | Conselheiro | 3 de Dezembro de 2021 J | 7.373 | 0 | 0 | $0 |
| Emergent BioSolutions Inc. | Detentor de 10% | 1 de Agosto de 2016 J | 0 | 0 | 0 | $0 |
| Soyoung Kwon | — | 6 de Agosto de 2026 M | 638 | 0 | 0 | $0 |
| Dirk Huebner | — | 6 de Agosto de 2026 M | 482 | 0 | 0 | $0 |
| Barbara Lopez Kunz | — | 6 de Agosto de 2026 M | 400 | 0 | 0 | $0 |
| Jeffrey G. Lamothe | — | 6 de Agosto de 2026 M | 961 | 0 | 0 | $0 |
| Grady Grant III | — | 6 de Agosto de 2026 M | 1.150 | 1 | 0 | $20.134 |
| John Niederhuber | — | 6 de Agosto de 2026 M | 400 | 0 | 0 | $0 |
| Marvin L White | — | 6 de Agosto de 2026 M | 1.261 | 0 | 0 | $0 |
| Daphne Taylor | — | 6 de Agosto de 2026 M | 638 | 0 | 0 | $0 |
| Daniel Abdun-Nabi | — | 6 de Agosto de 2026 M | 400 | 0 | 0 | $0 |
| Zsolt Harsanyi | — | 6 de Agosto de 2026 M | 400 | 0 | 0 | $0 |
Executivos de declarações SEC Formulário 3/4/5; líquido = apenas P/V de mercado aberto
Ativistas e proprietários de 5%+ 2 participações
Investidores que apresentaram o Schedule 13D da SEC — propriedade benéfica acima de 5% com a intenção de influenciar o emissor (participações ativistas, campanhas no conselho, M&A). Cada linha mostra o estado mais recente conhecido da posição desse declarante.
| Declarante | Declarado | Participação | Status | Propósito | Declaração |
|---|---|---|---|---|---|
| Tang Capital Partners, LP, Tang Capital Management, LLC, Kevin Tang ×6 declarações | 26 de Novembro de 2021 | — | Declaração inicial | — | SEC |
| Pessoa de relato não divulgada | 3 de Agosto de 2016 | — | Declaração inicial | — | SEC |
Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.
Participação em ETFs Detido por 1 ETF
O peso reflete apenas participações diretas em ações (N-PORT); fundos alavancados ou baseados em derivativos podem deter exposição adicional a swaps não mostrada.
| Fundo | Peso | Unidades | Em | Fonte |
|---|---|---|---|---|
| VXF · VANGUARD INDEX FUNDS | 0,00% | 12.713 SH | 8 de Agosto de 2026 | Diário |